Combination Primary Care and Prevention Services for Women Who Inject Drugs and Exchange Sex in Seattle, Washington

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 18, 2024

Primary Completion Date

March 12, 2025

Study Completion Date

March 12, 2025

Conditions
Opioid Use DisorderHIV InfectionsChlamydiaGonorrheaSyphilisTrichomonas
Interventions
OTHER

Mobile Van Clinic

The investigators will implement a pilot clinic one evening per week, with the primary goal of measuring a community-based extension of SHE Clinic's impact on uptake and sustained use of HIV pre-exposure prophylaxis (PrEP) and medications for opioid use disorder (MOUD). The clinic will be dispatched with a driver, nurse, physician, and research assistant. The van clinic will be outfitted with space to obtain a confidential history and physical exam and include a space for sample collection. In addition to standard of care, the investigators will provide participants with rapid point-of-care HIV and STI testing, and HIV PrEP and MOUD counseling and prescriptions.

Trial Locations (1)

98104

Harborview Medical Center, Seattle

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of Washington

OTHER

NCT06187064 - Combination Primary Care and Prevention Services for Women Who Inject Drugs and Exchange Sex in Seattle, Washington | Biotech Hunter | Biotech Hunter